Healthy adults
Conditions
Interventions
Duration: 12 weeks Test material: Soft capsule containing 7.5 mg of crocetin One capsule per day
Duration: 12 weeks Test material: Placebo soft capsule One capsule per day
Sponsors
ORTHOMEDICO, Inc.
Seishin-kai Medical Association Inc, Takara Medial Clinic.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy adults of Japanese
Exclusion criteria
Exclusion criteria: a) At least one previous medical history of malignant tumor, heart failure or myocardial infarction b) Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases c) Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily d) Currently taking medicines and/or herbal medicines e) Those who are allergic to medicines or foods related to the test material of this trial. f) Pregnant women, lactating women, or women who plan to become a pregnant during the trial period. g) Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial h) Others considered as inappropriate for the study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical examinations Hematological tests Blood biochemistry tests Urinalysis (0, 6, 12 week) | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaires of subjective symptoms | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO, Inc. R&D Department
Outcome results
None listed